0001127602-23-030172.txt : 20231220 0001127602-23-030172.hdr.sgml : 20231220 20231220161812 ACCESSION NUMBER: 0001127602-23-030172 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231219 FILED AS OF DATE: 20231220 DATE AS OF CHANGE: 20231220 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Watson David O. CENTRAL INDEX KEY: 0001657719 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38276 FILM NUMBER: 231501504 MAIL ADDRESS: STREET 1: 6400 WESTWIND WAY STREET 2: SUITE A CITY: CRESTWOOD STATE: KY ZIP: 40014 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Apellis Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001492422 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 271537290 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 FIFTH AVENUE CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 617-977-5700 MAIL ADDRESS: STREET 1: 100 FIFTH AVENUE CITY: WALTHAM STATE: MA ZIP: 02451 4 1 form4.xml PRIMARY DOCUMENT X0508 4 2023-12-19 0001492422 Apellis Pharmaceuticals, Inc. APLS 0001657719 Watson David O. C/O APELLIS PHARMACEUTICALS, INC 100 FIFTH AVENUE, 3RD FLOOR WALTHAM MA 02451 1 General Counsel 0 Common Stock 3333 I Indirect Owner (Custodial Account for Son) Common Stock 80705 I Indirect Owner (The David O. Watson Irrevocable Trust of 2023) Common Stock 6667 I Indirect Owner (The Watson Education Trust) Common Stock 2023-12-19 4 M 0 7905 13.85 A 93658 D Common Stock 2023-12-19 4 S 0 1605 57.0041 D 92053 D Common Stock 2023-12-19 4 S 0 2300 57.3827 D 89753 D Stock Option (Right to Buy) 13.85 2023-12-19 4 M 0 7905 0 D 2029-02-07 Common Stock 7905 3762 D This represents a custodial account held by the reporting person for the sole benefit of his minor son. The securities are held by The David O. Watson Irrevocable Trust of 2023. William Zorn is the trustee of The David O. Watson Irrevocable Trust of 2023. The reporting person disclaims beneficial ownership over the shares held by The David O. Watson Irrevocable Trust of 2023 except to the extent of his pecuniary interest therein. The securities are held by The Watson Education Trust (the "Trust"), for which the reporting person serves as trustee. The reporting person disclaims beneficial ownership over the shares held by the Trust except to the extent of his pecuniary interest therein. This transaction was executed in multiple trades at prices ranging from $56.290 - $57.280. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $57.300 - $57.830. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This option was granted on February 8, 2019 and is fully vested. David Watson 2023-12-20